Navigation Links
Haemonetics Reports Second Quarter Fiscal 2013 Revenue Up 22%, Organic Revenue Up 6% and Adjusted EPS of $0.90, Reaffirms Fiscal 2013 Guidance and Announces Two-For-One Stock Split
Date:10/29/2012

BRAINTREE, Mass., Oct. 29, 2012 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today reported second quarter 2013 net revenue of $218.2 million, up 22%, GAAP net income of $6.5 million, down 53%, and diluted earnings per share of $0.25, down 53%.  Excluding restructuring, transformation, integration and transaction costs, adjusted net income was $23.5 million, up 26%, and adjusted earnings per share were $0.90, up 25%.  Organic net revenue, exclusive of the recently acquired whole blood business, was $189.6 million, up 6%. Excluding currency impacts, net revenue was up 22% in total and 6% on an organic basis.[1]

(Logo:  http://photos.prnewswire.com/prnh/20120206/NE47232LOGO )

Brian Concannon, Haemonetics' President and CEO, commented: "The highlights of our second quarter were the successful acquisition of the whole blood business and continued organic revenue growth in disposables across our entire product portfolio, especially in our Hospital business where 14% second quarter growth followed 11% growth in the first quarter.  Strong demand for the Cell Saver® Elite® and TEG® disposables, and growth in our OrthoPAT® business, provide strong evidence that our Hospital customers continue to embrace our Blood Management Solutions recognizing the inherent value proposition offered."STRATEGIC AND PRODUCT GROWTH HIGHLIGHTSHaemonetics continues to make progress expanding its business, reporting the following highlights:

  • 22% revenue growth including 6% organic revenue growth.
  • 7% revenue growth in plasma disposables.
  • 16% revenue growth in surgical disposables.
  • 23% revenue growth in diagnostic disposables.
  • 5% revenue growth in OrthoPAT disposables, a return to growth as
    '/>"/>

  • SOURCE Haemonetics Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

    Related biology technology :

    1. Haemonetics Reports First Quarter Fiscal 2013 Results, Completes Acquisition of Palls Transfusion Medicine Business, Affirms Fiscal 2013 Earnings Guidance, Provides Preliminary Outlook for Fiscal 2014 and Announces Share Repurchase
    2. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
    3. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
    4. Interleukin Genetics Reports Third Quarter 2011 Financial Results
    5. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
    6. Nile Therapeutics Reports 2011 Third Quarter Financial Results
    7. Pharmasset Reports Fiscal Year End 2011 Financial Results
    8. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
    9. SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results
    10. WaferGen Reports Third Quarter 2011 Financial Results and Announces New Commercialization Strategy
    11. Hadasit Bio-Holdings Ltd. Reports Significant External Financing for Portfolio Companies
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/27/2015)... -- SynGen Inc., a company that focuses on the ... and progenitor cells from umbilical cord blood, bone marrow, ... has added three new members to its management team ... focus on product commercialization. Chuck Novak ... and Chief Financial Officer.  Chuck was most recently CFO ...
    (Date:4/27/2015)... 27, 2015 DryLet, LLC a ... applications such as animal waste reduction, bioremediation, wastewater ... in wastewater treatment plants and restaurant kitchen settings, ... the Texas Commission on Environmental Quality (TCEQ) Environmental ... Texas. , The company will highlight three of ...
    (Date:4/27/2015)... Diasome Pharmaceuticals, Inc. (“Diasome”) has ... Diabetes Center (“Joslin”) to collaborate on the design ... Hepatocyte Directed Vesicle (“HDV”) targeting system for insulin ... Located in Boston, Massachusetts, Joslin is the world's ... dedicated to the prevention, treatment and cure of ...
    (Date:4/25/2015)... Join us for a webinar at ... Residence Times using the Transcreener® ADP Assay , ... is increasingly being incorporated into lead development efforts because ... efficacy, increased therapeutic window and reduced side effects. ... methods such surface plasmon resonance, conjugation of drugs can ...
    Breaking Biology Technology:SynGen Inc. Expands Its Management Team 2DryLet to Showcase Multiple Products at Texas Commission on Environmental Quality Trade Fair and Conference May 5-6 in Austin, Texas 2Diasome Pharmaceuticals Announces Clinical Trial Design Collaboration 2BellBrook Labs Webinar: Analyzing Kinase Inhibitor Residence Times using the Transcreener® ADP Assay 2
    ... a privately-held biotechnology company, has completed what it calls a ... to pursue a new partnership with a large pharmaceutical company. ... the identity of the pharma company would not be announced ... GenTel's new facility in the Fitchburg Technology Campus . ...
    ... - Johnson Controls , responding to increasing global ... of a new business division to develop and service ... technologies unit will focus on geothermal, solar, biomass, wind, ... ,Johnson Controls expects increased demand for these alternative forms ...
    ... Waukesha, Wis. - RedPrairie Corp. has ... a developer of fleet-management software based in Quebec City, ... but the acquisition is expected to close by the ... supply-chain software, said the combined companies will operate under ...
    Cached Biology Technology:New angel capital centered on GenTel agreement with big pharma 2
    (Date:4/6/2015)... 6, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, ... 62/143028 for MINIATURE, MULTI-PURPOSE ANTENNA METHOD AND ... NXT-ID introduces a new revolutionary method and ... the use of miniature antenna modules for multiple ...
    (Date:4/1/2015)... Conn. , Apr. 1, 2015  NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... of Wocket smart wallets is underway to early access ... access group includes usage at retail outlets including Walmart, ... Pharmacy. Users report Wocket was accepted at all outlets ...
    (Date:3/26/2015)... March 26, 2015 The Granite ... recreation and athletic club, today announced it has implemented ... freedom of movement for members and staff, while restricting ... comprehensive process, we selected FST,s IMID Access system because ... for our members and staff, in addition to unparalleled ...
    Breaking Biology News(10 mins):NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2
    ... football players top of mind, parents and coaches should always ... professor and neuropsychologist at the University of Denver (DU), says ... during a game. Most concussions deliver 95 Gs to the ... the Colorado Youth Sports Concussion Special Interest Group, says the ...
    ... Topics ranging from the future of addiction research ... of drugs will be presented at the 10th Annual ... on Drug Abuse September 30 - October 2, 2010 ... hosted by LSU Health Sciences Center New Orleans, was ...
    ... (Sept. 22, 2010) -- From helping to decipher ... as a model organism, and from directing the Laboratory ... the world, Nobel Prize winner Sydney Brenner has had a ... much as Brenner in both research and administration of science, ...
    Cached Biology News:White House policy advisor talks about legalized drugs 2Biography captures Sydney Brenner's unflagging scientific curiosity and lively personality 2
    ... are stored within neurons in vesicles ... in the synaptic bouton. Synaptosomes ... from other cellular debris. Abnormalites ... in many pathological condtions. Conditions ...
    ... The GenePix Professional 4200A can be upgraded ... Autoloader automatically loads, scans, analyzes, and saves ... notifies you by email when the batch ... uniformity, even for warped slides. GenePix Pro ...
    ... provide a fast, easy to use, reproducible ... They are 15 times faster and 5 ... than 5%). ,The VoluPAC tubes enable the ... in a cell suspension, resulting in absolute ...
    ... Maximize the value of your microarray data ... support you need from consultation to extensive ... date methods. Utilize our expertise in combination ... from your own microarray experiments., ,Normalization and ...
    Biology Products: